Integrated bioinformatics analysis for identifying fibroblast-associated biomarkers and molecular subtypes in human

Chuying Gui1, Sidi Liu1, Zhike Fu1

  • 1The Department of Nephrology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.

Heliyon
|November 11, 2024
PubMed
Abstract

Insights

This study identifies fibroblast-associated molecular subtypes in membranous nephropathy (MN) using bioinformatics. COL3A1 is highlighted as a key biomarker for potential diagnosis and therapy in MN patients.

Area of Science:

  • Nephrology
  • Immunology
  • Bioinformatics
  • Genomics

Background:

  • Membranous nephropathy (MN) involves immune complex deposition in the glomerular basement membrane, causing proteinuria and kidney dysfunction.
  • Fibroblasts play a role in MN pathogenesis through tissue remodeling and immune modulation.

Purpose of the Study:

  • To identify fibroblast-associated biomarkers and molecular subtypes in membranous nephropathy (MN).
  • To investigate the role of fibroblasts in MN pathogenesis using integrated bioinformatics analyses.

Main Methods:

  • Utilized xCell algorithm for fibroblast infiltration assessment.
  • Employed weighted gene co-expression network analysis (WGCNA) to identify fibroblast-related gene modules.
  • Performed differential gene expression analysis and protein-protein interaction network construction to screen for differentially expressed fibroblast-associated genes (DEFAGs).
  • Applied consensus clustering to categorize MN patients into molecular subtypes based on DEFAG expression.

Main Results:

  • Fibroblast scores were significantly elevated in MN patients compared to healthy controls (HC).
  • WGCNA identified key gene modules (brown and turquoise) strongly correlated with fibroblast scores.
  • Identified 308 overlapping DEFAGs between WGCNA and differential expression analysis.
  • Discovered two distinct molecular subtypes (C1 and C2) in MN, enriched for immune response and extracellular matrix remodeling pathways.
  • Highlighted COL3A1 and TGFB1 as central biomarkers with elevated expression in MN.

Conclusions:

  • Integrated bioinformatics analysis revealed fibroblast-associated molecular subtypes in MN with distinct immune profiles.
  • COL3A1 is identified as a potential diagnostic and therapeutic target for membranous nephropathy.
  • Findings implicate COL3A1 in immune regulation and disease progression in MN.